Viewing Study NCT04608318

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:02 AM

Ignite Modification Date: 2025-12-26 @ 4:03 AM

Study NCT ID: NCT04608318

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2024-12-31

First Post: 2020-10-23

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Sponsor: German CLL Study Group

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module